Filing Details
- Accession Number:
- 0001179110-14-005102
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-03-12 17:01:48
- Reporting Period:
- 2014-03-07
- Filing Date:
- 2014-03-12
- Accepted Time:
- 2014-03-12 17:01:48
- Original Submission Date:
- 2014-03-11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 821995 | Columbia Laboratories Inc | CBRX | Pharmaceutical Preparations (2834) | 592758596 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1496606 | Coventry Acquisition, Llc | C/O Actavis Chief Legal Counsel Morris Corp Ctr Iii, 400 Interpace Pkwy Parsippany NJ 07054 | No | No | Yes | No | |
| 1578845 | Plc Actavis | C/O Actavis Chief Legal Officer Morris Corp Ctr Iii, 400 Interpace Pkwy Parsippany NJ 07054 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-03-07 | 1,400,000 | $6.08 | 0 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
Footnotes
- The shares reported herein reflect the 1-for-8 reverse stock split of the Issuer's common stock which took effect on August 9, 2013.
- Coventry Acquisition LLC, the direct record holder of the shares reported herein, is an indirect subsidiary of Actavis plc.
- This amendment to Form 4 is being filed solely to correct the price per share amount in Column 4 from $5.76 to $6.0779.
Billionaire Hedge Funds
